GlassScriptPhysician profile
Jacqueline Dallaire
NPI 1891218863
$496.80
in general payments reported to CMS, 2019-2025
11 companies · $403 in 2025
The $403 reported for 2025 was more than what 75% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $93.54 · 2025: $403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $496.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $176.07 | 2024-2025 | |
| Hologic Sales and Service, LLC | $85.96 | 2025 | Coolseal Generator |
| Exeltis, USA INC. | $51.98 | 2024-2025 | Slynd |
| Sumitomo Pharma America, INC. | $34.82 | 2025 | Myfembree |
| Sage Therapeutics, LLC | $30.80 | 2024-2025 | Zurzuvae |
| Exact Sciences Corporation | $27.12 | 2025 | The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $25.50 | 2025 | |
| Evofem Biosciences, INC. | $16.86 | 2025 | Phexxi, Solosec, Phexx |
| Pfizer INC. | $16.78 | 2025 | |
| Acella Pharmaceuticals, LLC | $16.00 | 2025 | NP Thyroid 60 |
| Astellas Pharma US INC | $14.91 | 2025 | Veozah |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Dallaire listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.